CCNA2 as an Immunological Biomarker Encompassing Tumor Microenvironment and Therapeutic Response in Multiple Cancer TypesAimin Jiang, Linhui Wang, Ye Zhou et al.|Oxidative Medicine and Cellular Longevity|2022Cited by 65
Elevated SNRPA1, as a Promising Predictor Reflecting Severe Clinical Outcome via Effecting Tumor Immunity for ccRCC, Is Related to Cell Invasion, Metastasis, and Sunitinib SensitivityAimin Jiang, Linhui Wang, Jialin Meng et al.|Frontiers in Immunology|2022Cited by 25
RNA modification pattern‐based subtypes reveal heterogenous clinical outcomes and tumor immunity of clear cell renal cell carcinomaAimin Jiang, Linhui Wang, Zi‐jun Xu et al.|MedComm – Future Medicine|2023Cited by 9
Definition and verification of novel metastasis and recurrence related signatures of ccRCC: A multicohort studyAimin Jiang, Linhui Wang, Qingyang Pang et al.|Cancer Innovation|2022Cited by 8